Anti-coagulant activity of a metalloprotease: Further characterization from the Indian cobra (Naja naja) venom

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 3, 2010, Pages 340-348

  Kumar, M S ^a   Devaraj, V R ^b   Vishwanath, B S ^a   Kemparaju, K ^a  

^a UNIVERSITY OF MYSORE   (India)

^b BANGALORE UNIVERSITY   (India)

Author keywords

Alpha polymer; Anticoagulant activity; Defibrinogenating activity; Elapid venom; Fibrin(ogen)olytic activity; SVMPs

Indexed keywords

ALPHA 2 MACROGLOBULIN; DIMER; FIBRIN; FIBRINOGEN; METALLOPROTEINASE; SNAKE VENOM ANTISERUM; SNAKE VENOM METALLOPROTEINASE; SNAKE VENOM METALLOPROTEINASE NN PF3; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; SNAKE VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLEEDING TIME; BLOOD ANALYSIS; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBRINOGEN BLOOD LEVEL; FIBRINOGENOLYSIS; HUMAN; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN POLYMERIZATION; PROTHROMBIN TIME; THROMBIN TIME; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; ELAPIDAE; ENZYMOLOGY; INDIA; ISOLATION AND PURIFICATION; PHYSIOLOGY;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; COBRA; COBRA VENOMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDIA; METALLOPROTEASES; MICE; ELAPIDAE;

EID: 77954951951     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0379-2     Document Type: Article

References (27)

1. Koh DC, Armugam A, Jeyaseelan K (2006) Snake venom components and their applications in biomedicine. Cell Mol Life Sci 63:3030-3041. doi:10.1007/s00018-006-6315-0 (Pubitemid 46072306)
2. Larréché S, Mion G, Goyffon M (2008) Haemostasis disorders caused by snake venoms. Ann Fr Anesth Reanim 27:302-309. doi:10.1016/j.annfar. 2008.02.009
3. Zhu ZG, Wu SG (1999) Fibrinogenolytic properties of natrahagin (a proteinase from cobra venom) and its effect on human platelet aggregation. Zhongguo Yao Li Xue Bao 20:944-947
4. Kini RM, Evans HJ (1991) Inhibition of platelet aggregation by a fibrinogenase from Naja nigricollis venom is independent of fibrinogen degradation. Biochim Biophys Acta 1095:117-121. doi:10.1016/0167-4889 (91) 90073-7
5. Guo XX, Zeng L, Lee WH et al (2007) Isolation and cloning of a metalloproteinase from king cobra snake venom. Toxicon 49:954-965. doi:10.1016/j.toxicon. 2007.01.003
6. Matsui T, Fujimura Y, Titani K (2000) Snake venom proteases affecting hemostasis and thrombosis. Biochim Biophys Acta 1477:146-156
7. Zingali RB, Ferreira MS, Assafim M et al (2005) Bothrojaracin, a Bothrops jararaca snake venom-derived (pro) thrombin inhibitor, as an anti-thrombotic molecule. Pathophysiol Haemost Thromb 34:160-163. doi:10.1159/000092416
8. Zhang Y, Wisner A, Xiong Y et al (1995) A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning. J Biol Chem 270:10246-10255. doi: 10.1074/jbc.270.17.10246
9. Sanchez EF, Felicori LF, Chavez-Olortegui C et al (2006) Biochemical characterization and molecular cloning of a plasminogen activator proteinase (LV-PA) from bushmaster snake venom. Biochim Biophys Acta 1760:1762-1771
10. Kisiel W, Kondo S, Smith KJ et al (1987) Characterization of a protein C activator from Agkistrodon contortrix contortrix venom. J Biol Chem 262:12607-12613
11. Jagadeesha DK, Shashidhara murthy R, Girish KS et al (2002) A non-toxic anticoagulant metalloprotease: purification and characterization from Indian cobra (Naja naja naja) venom. Toxicon 40:667-675. doi:10.1016/S0041-0101 (01) 00216-1
12. Gené JA, Roy A, Rojas G et al (1989) Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 27:841-848. doi:10.1016/0041-0101 (89) 90096-2
13. Rajesh R, Raghavendra Gowda CD, Nataraju A et al (2005) Procoagulant activity of Calotropis gigantea latex associated with fibrin (ogen) olytic activity. Toxicon 46:84-92. doi:10.1016/j.toxicon. 2005.03.012
14. Evans HJ (1981) Cleavage of the A alpha-chain of fibrinogen and the alpha-polymer of fibrin by the venom of spitting cobra (Naja nigricollis). Biochim Biophys Acta 660:219-226
15. Daoud E, Tu AT, el-Asmar MF (1986) Mechanism of the anticoagulant, Cerastase F-4, isolated from Cerastes cerastes (Egyptian sand viper) venom. Thromb Res 41:791-799. doi:10.1016/0049-3848 (86) 90377-4 (Pubitemid 16139605)
16. Chakrabarty D, Datta K, Gomes A et al (2000) Haemorrhagic protein of Russell's viper venom with fibrinolytic and esterolytic activities. Toxicon 38:1475-1490. doi:10.1016/S0041-0101 (99) 00243-3
17. Loria GD, Rucavado A, Kamiguti AS et al (2003) Characterization of 'basparin A', a prothrombin-activating metalloproteinase, from the venom of the snake Bothrops asper that inhibits platelet aggregation and induces defibrination and thrombosis. Arch Biochem Biophys 418:13-24. doi:10.1016/S0003-9861 (03) 00385-0
18. Denis C, Methia N, Frenette PS et al (1998) A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 95:9524-9529. doi: 10.1073/pnas.95.16.9524 (Pubitemid 28506264)
19. Bernardes CP, Santos-Filho NA, Costa TR et al (2008) Isolation and structural characterization of a new fibrin (ogen) olytic metalloproteinase from Bothrops moojeni snake venom. Toxicon 51:574-584. doi:10.1016/j.toxicon. 2007.11.017
20. Reid HA, Chan KE (1968) The paradox in therapeutic defibrination. Lancet 1:485-486. doi:10.1016/S0140-6736 (68) 91463-3
21. Gomes A, De P (1999) Hannahpep: a novel fibrinolytic peptide from the Indian King Cobra (Ophiophagus hannah) venom. Biochem Biophys Res Commun 266:488-491. doi:10.1006/bbrc.1999.1818 (Pubitemid 30028694)
22. Markland FS (1998) Snake venom fibrinogenolytic and fibrinolytic enzymes: an updated inventory. Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 79:668-674
23. Laing GD, Moura-da-Silva AM (2005) Jararhagin and its multiple effects on hemostasis. Toxicon 45:987-996. doi:10.1016/j.toxicon. 2005.02.013
24. Estêvão-Costa MI, Diniz CR, Magalhães A (2000) Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems. Thromb Res 99:363-376. doi:10.1016/S0049-3848 (00) 00259-0
25. Bello CA, Hermogenes AL, Magalhaes A (2006) Isolation and biochemical characterization of a fibrinolytic proteinase from Bothrops leucurus (white-tailed jararaca) snake venom. Biochimie 88:189-200. doi:10.1016/j.biochi. 2005.07.008 (Pubitemid 41668610)
26. Fox JW, Serrano SM (2005) Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45:969-985. doi:10.1016/j.toxicon. 2005.02.012
27. Moura-da-Silva AM, Ramos OH, Baldo C et al (2008) Collagen binding is a key factor for the hemorrhagic activity of snake venom metalloproteinases. Biochimie 90:484-492. doi:10.1016/j.biochi.2007.11.009